These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 33052427)
41. CXCL13 inhibition induce the apoptosis of MDA-MB-231 breast cancer cells through blocking CXCR5/ERK signaling pathway. Ma JJ; Jiang L; Tong DY; Ren YN; Sheng MF; Liu HC Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8755-8762. PubMed ID: 30575916 [TBL] [Abstract][Full Text] [Related]
42. Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia. Gang EJ; Hsieh YT; Pham J; Zhao Y; Nguyen C; Huantes S; Park E; Naing K; Klemm L; Swaminathan S; Conway EM; Pelus LM; Crispino J; Mullighan CG; McMillan M; Müschen M; Kahn M; Kim YM Oncogene; 2014 Apr; 33(17):2169-78. PubMed ID: 23728349 [TBL] [Abstract][Full Text] [Related]
43. miR-221/222 activate the Wnt/β-catenin signaling to promote triple-negative breast cancer. Liu S; Wang Z; Liu Z; Shi S; Zhang Z; Zhang J; Lin H J Mol Cell Biol; 2018 Aug; 10(4):302-315. PubMed ID: 30053090 [TBL] [Abstract][Full Text] [Related]
44. ATF4 promotes lung cancer cell proliferation and invasion partially through regulating Wnt/β-catenin signaling. Du J; Liu H; Mao X; Qin Y; Fan C Int J Med Sci; 2021; 18(6):1442-1448. PubMed ID: 33628101 [TBL] [Abstract][Full Text] [Related]
45. Label-Free Quantitative Proteomics Combined with Biological Validation Reveals Activation of Wnt/β-Catenin Pathway Contributing to Trastuzumab Resistance in Gastric Cancer. Liu W; Yuan J; Liu Z; Zhang J; Chang J Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986466 [TBL] [Abstract][Full Text] [Related]
46. Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells. Bilir B; Kucuk O; Moreno CS J Transl Med; 2013 Nov; 11():280. PubMed ID: 24188694 [TBL] [Abstract][Full Text] [Related]
47. A novel humanized Frizzled-7-targeting antibody enhances antitumor effects of Bevacizumab against triple-negative breast cancer via blocking Wnt/β-catenin signaling pathway. Xie W; Zhao H; Wang F; Wang Y; He Y; Wang T; Zhang K; Yang H; Zhou Z; Shi H; Wang J; Huang G J Exp Clin Cancer Res; 2021 Jan; 40(1):30. PubMed ID: 33436039 [TBL] [Abstract][Full Text] [Related]
48. Rottlerin induces Wnt co-receptor LRP6 degradation and suppresses both Wnt/β-catenin and mTORC1 signaling in prostate and breast cancer cells. Lu W; Lin C; Li Y Cell Signal; 2014 Jun; 26(6):1303-9. PubMed ID: 24607787 [TBL] [Abstract][Full Text] [Related]
49. Baicalein suppresses the proliferation of human cervical cancer cells via Notch 1/Hes signaling pathway. Lian H; Hui Y; Xiaoping T; Wei T; Jiyi X; Xiaolan Y J Cancer Res Ther; 2019; 15(6):1216-1220. PubMed ID: 31898650 [TBL] [Abstract][Full Text] [Related]
50. 5-Acetyl goniothalamin suppresses proliferation of breast cancer cells via Wnt/β-catenin signaling. Boonmuen N; Thongon N; Chairoungdua A; Suksen K; Pompimon W; Tuchinda P; Reutrakul V; Piyachaturawat P Eur J Pharmacol; 2016 Nov; 791():455-464. PubMed ID: 27640746 [TBL] [Abstract][Full Text] [Related]
51. Additive Pharmacological Interaction between Cisplatin (CDDP) and Histone Deacetylase Inhibitors (HDIs) in MDA-MB-231 Triple Negative Breast Cancer (TNBC) Cells with Altered Notch1 Activity-An Isobolographic Analysis. Wawruszak A; Luszczki JJ; Kalafut J; Okla K; Halasa M; Rivero-Muller A; Stepulak A Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357442 [TBL] [Abstract][Full Text] [Related]
52. Wnt-beta-catenin pathway signals metastasis-associated tumor cell phenotypes in triple negative breast cancers. De P; Carlson JH; Wu H; Marcus A; Leyland-Jones B; Dey N Oncotarget; 2016 Jul; 7(28):43124-43149. PubMed ID: 27281609 [TBL] [Abstract][Full Text] [Related]
53. MiR-125b regulates the proliferation and metastasis of triple negative breast cancer cells via the Wnt/β-catenin pathway and EMT. Nie J; Jiang HC; Zhou YC; Jiang B; He WJ; Wang YF; Dong J Biosci Biotechnol Biochem; 2019 Jun; 83(6):1062-1071. PubMed ID: 30950326 [TBL] [Abstract][Full Text] [Related]
54. Antrodia camphorata inhibits epithelial-to-mesenchymal transition by targeting multiple pathways in triple-negative breast cancers. Hseu YC; Chang GR; Pan JY; Rajendran P; Mathew DC; Li ML; Liao JW; Chen WT; Yang HL J Cell Physiol; 2019 Apr; 234(4):4125-4139. PubMed ID: 30146779 [TBL] [Abstract][Full Text] [Related]
55. The natural compound Jatrophone interferes with Wnt/β-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer. Fatima I; El-Ayachi I; Taotao L; Lillo MA; Krutilina RI; Seagroves TN; Radaszkiewicz TW; Hutnan M; Bryja V; Krum SA; Rivas F; Miranda-Carboni GA PLoS One; 2017; 12(12):e0189864. PubMed ID: 29281678 [TBL] [Abstract][Full Text] [Related]
56. Dual Src Kinase/Pretubulin Inhibitor KX-01, Sensitizes ERα-negative Breast Cancers to Tamoxifen through ERα Reexpression. Anbalagan M; Sheng M; Fleischer B; Zhang Y; Gao Y; Hoang V; Matossian M; Burks HE; Burow ME; Collins-Burow BM; Hangauer D; Rowan BG Mol Cancer Res; 2017 Nov; 15(11):1491-1502. PubMed ID: 28751463 [TBL] [Abstract][Full Text] [Related]
57. Inhibition of the Wnt/β-Catenin Pathway Overcomes Resistance to Enzalutamide in Castration-Resistant Prostate Cancer. Zhang Z; Cheng L; Li J; Farah E; Atallah NM; Pascuzzi PE; Gupta S; Liu X Cancer Res; 2018 Jun; 78(12):3147-3162. PubMed ID: 29700003 [TBL] [Abstract][Full Text] [Related]
58. NLRP3 augmented resistance to gemcitabine in triple-negative breast cancer cells via EMT/IL-1β/Wnt/β-catenin signaling pathway. Zheng Q; Yao D; Cai Y; Zhou T Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32578856 [TBL] [Abstract][Full Text] [Related]
59. Gypensapogenin I Suppresses Cell Proliferation in Triple-Negative Breast Cancer Via Triggering the Closure of AKT/GSK3β/β-Catenin and Notch-1 Signaling Pathways. Tan H; Li M; Han L; Zhao Y; Zhang X J Agric Food Chem; 2022 May; 70(17):5438-5449. PubMed ID: 35465659 [TBL] [Abstract][Full Text] [Related]
60. Targeting Wnt/β-catenin and PI3K/Akt/mTOR pathways in T-cell acute lymphoblastic leukemia. Evangelisti C; Chiarini F; Cappellini A; Paganelli F; Fini M; Santi S; Martelli AM; Neri LM; Evangelisti C J Cell Physiol; 2020 Jun; 235(6):5413-5428. PubMed ID: 31904116 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]